# Ching-Yi Chen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ching-yi-chen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 301 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 11 |
| i10-index | 11 |
| Last Known Institution | E-Da Hospital |
| OpenAlex ID | https://openalex.org/A5100757472 |
| ORCID iD | 0000-0002-3320-1680 |
| Works | 41 |

## Researcher papers

- [Role of the <i>mecA</i> Gene in Oxacillin Resistance in a Staphylococcus aureus Clinical Strain with a <i>pvl</i> -Positive ST59 Genetic Background](https://scholariq.org/papers/role-of-the-i-meca-i-gene-in-oxacillin-resistance-in-a-staphylococcus-aureus/)
- [Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials](https://scholariq.org/papers/clinical-efficacy-and-safety-of-janus-kinase-inhibitors-for-covid-19-a/)
- [Ancient schwannoma of the mouth floor – A case report and review](https://scholariq.org/papers/ancient-schwannoma-of-the-mouth-floor-a-case-report-and-review/)
- [An investigation of the mean reversion of hospitality stock prices towards their fundamental values: The case of Taiwan](https://scholariq.org/papers/an-investigation-of-the-mean-reversion-of-hospitality-stock-prices-towards-their/)
- [Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials](https://scholariq.org/papers/effect-of-sofosbuvir-based-treatment-on-clinical-outcomes-of-patients-with-covid/)
- [LABA/LAMA fixed-dose combinations <i>versus</i> LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis](https://scholariq.org/papers/laba-lama-fixed-dose-combinations-i-versus-i-lama-monotherapy-in-the-prevention/)
- [Chemotherapy or Chemo-Immunotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer: A Meta-Analysis](https://scholariq.org/papers/chemotherapy-or-chemo-immunotherapy-as-first-line-treatment-for-extensive-stage/)
- [The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials](https://scholariq.org/papers/the-effect-of-intravenous-immunoglobulins-on-the-outcomes-of-patients-with-covid/)
- [The impact of vitamin C-containing treatment on the mortality of patients with sepsis: A systematic review and meta-analysis of randomized controlled trials](https://scholariq.org/papers/the-impact-of-vitamin-c-containing-treatment-on-the-mortality-of-patients-with/)
- [Correlating Reiff scores with clinical, functional, and prognostic factors: characterizing noncystic fibrosis bronchiectasis severity: validation from a nationwide multicenter study in Taiwan](https://scholariq.org/papers/correlating-reiff-scores-with-clinical-functional-and-prognostic-factors/)
- [Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer](https://scholariq.org/papers/impact-of-subsequent-treatment-on-clinical-outcomes-in-patients-with-egfr-mutant/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [E-Da Hospital](https://scholariq.org/institutions/e-da-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.